Rawcliffe Adrian

EDGAR CIK 0001555851

Adaptimmune Therapeutics Plc - ADAP

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CEO Director
Chief Executive Officer
Direct Buys
0
$0
0 Shares
Direct Sells
3
($52,413)
-90,170 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/17/2025
01/17/2025
Sell
-30,601 @ $0.58
 ($17,773) 44,327 (-40.84%) Direct
01/15/2025
01/15/2025
Sell
-29,096 @ $0.57
 ($16,724) 41,582 (-41.17%) Direct
01/13/2025
01/15/2025
Sell
-30,473 @ $0.59
 ($17,915) 25,711 (-54.24%) Direct